Summary of Classification and Labelling
Notified classification and labelling
General Information
EC / List no.
|
Name |
CAS Number
|
---|---|---|
220-863-9 | 11β,17,21-trihydroxy-6α-methylpregna-1,4-diene-3,20-dione 21-(hydrogen succinate) | 2921-57-5 |
Notified classification and labelling according to CLP criteria
Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
---|---|---|---|---|---|---|---|---|---|---|---|
Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
Repr. 1B | H360 (Development) | H360 |
GHS08 Dgr |
State/Form
|
5 | View details | |||||
STOT RE 2 | H373 | H373 | |||||||||
Repr. 1A | H360 (Developmental) | H360 (Developmental) |
GHS08 Dgr |
State/Form
|
29 | View details | |||||
STOT RE 2 | H373 (Blood Forming o...) | H373 (Blood Forming o...) | |||||||||
Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Wng |
State/Form
|
17 | View details | |||||
Acute Tox. 4 | H312 | H312 | |||||||||
Repr. 2 | H361 (H361d Suspected...) | H361 (H361d Suspected...) | |||||||||
Repr. 1A | H360 | H360 |
GHS08 Dgr |
State/Form
|
1 | View details | |||||
STOT RE 2 | H373 (data lacking) | H373 | |||||||||
Repr. 2 | H361 | H361 (H361d Suspected...) |
GHS08 Wng |
1 | View details | ||||||
Carc. 2 | H351 | H351 |
GHS08 Wng |
State/Form
|
1 | View details | |||||
Repr. 2 | H361 | H361 | |||||||||
Repr. 1B | H360D (Development) | H360D |
GHS08 Dgr |
State/Form
|
1 | View details | |||||
STOT RE 2 | H373 (blood) (oral) |
Number of Aggregated Notifications: 7